Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Meiragtx Holdings Plc (MGTX)
NASDAQ:MGTX
Meiragtx Holdings (MGTX) Stock Price & Analysis
396 Followers
MGTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.49 - $8.35
Previous Close$5.01
Volume235.24K
Average Volume (3M)147.65K
Market Cap
$318.62M
Enterprise Value$278.32M
Total Cash (Recent Filing)$129.57M
Total Debt (Recent Filing)$89.26M
Price to Earnings (P/E)-3.2
Beta1.54
Next Earnings
May 09, 2024EPS Estimate
-$0.51Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.58
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume147,651
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-2.53
Forecast
1Y Price Target
$13.00Price Target Upside159.48% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Meiragtx Holdings News
Bulls Say, Bears Say
Bulls Say
Clinical DevelopmentThe company has aligned with FDA on requirements for ongoing phase 2 AQUAx2 clinical trial, which supports potential BLA filing and adds another asset to watch.
Financial ForecastMultiple partnerships have bolstered the company's cash position, providing a solid financial foundation for near-term operations.
Strategic InvestmentThe company has secured a strategic investment from Sanofi and an asset purchase agreement with Janssen, enhancing the financial stability and future growth prospects.
Bears Say
Clinical Trial ResultsIn comparing with the prior data, there is observed variability with some patients showing a decline in improvement scores.
Market UncertaintyThere are concerns about uncertainties around launch and ramp trajectories for gene therapy modalities.
Stock PerformanceStock has traded down this year, underperforming the broader biotech index.
---
Ownership Overview
35.47% Insiders
4.19% Mutual Funds
3.47% Other Institutional Investors
56.87% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MGTX FAQ
What was Meiragtx Holdings Plc’s price range in the past 12 months?
Meiragtx Holdings Plc lowest stock price was $3.49 and its highest was $8.35 in the past 12 months.
What is Meiragtx Holdings Plc’s market cap?
Currently, no data Available
When is Meiragtx Holdings Plc’s upcoming earnings report date?
Meiragtx Holdings Plc’s upcoming earnings report date is May 09, 2024 which is in 16 days.
How were Meiragtx Holdings Plc’s earnings last quarter?
Meiragtx Holdings Plc released its earnings results on Mar 14, 2024. The company reported $0.4 earnings per share for the quarter, beating the consensus estimate of $0.025 by $0.375.
Is Meiragtx Holdings Plc overvalued?
According to Wall Street analysts Meiragtx Holdings Plc’s price is currently Undervalued.
Does Meiragtx Holdings Plc pay dividends?
Meiragtx Holdings Plc does not currently pay dividends.
What is Meiragtx Holdings Plc’s EPS estimate?
Meiragtx Holdings Plc’s EPS estimate is -$0.51.
How many shares outstanding does Meiragtx Holdings Plc have?
Meiragtx Holdings Plc has 63,597,153 shares outstanding.
What happened to Meiragtx Holdings Plc’s price movement after its last earnings report?
Meiragtx Holdings Plc reported an EPS of $0.4 in its last earnings report, beating expectations of $0.025. Following the earnings report the stock price went down -7.087%.
Which hedge fund is a major shareholder of Meiragtx Holdings Plc?
Among the largest hedge funds holding Meiragtx Holdings Plc’s share is Perceptive Advisors LLC. It holds Meiragtx Holdings Plc’s shares valued at 80M.
---
Meiragtx Holdings Stock Smart Score
Company Description
Meiragtx Holdings Plc
MeiraGTx Holdings Plc is a clinical-stage biotech company, which engages in the development of novel gene therapy treatments. It operates through the United States and United Kingdom geographical segments. Its pipeline includes AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1, and AAV-UPF1. The company was founded on March 20, 2015 and is headquartered in New York, NY.
---
MGTX Stock 12 Months Forecast
Average Price Target
$13.00
▲(159.48% Upside)
Technical Analysis
Best Analysts Covering MGTX
1 Year
1 Year Success Rate
3/14 ratings generated profit
1 Year Average Return
-19.35%
assigned a buy rating last month
Copying Luca Issi's trades and holding each position for 1 Year would result in 21.43% of your transactions generating a profit, with an average return of -19.35% per trade.
---